It satisfies our precise strategic consideration of tumor radiation sensitization; through the inhibition of Wnt5a or its downstream target gene Beclin1, we can accurately reverse the radiation resistance effect of tumor cells without too many side effects on normal cells. The gene discussed is BECN1; the disease is neoplasm.